Read This Before You Book a Hair Transplant

Clinical illustration showing three treatment pathways converging on a single hair follicle, representing the three-pillar hair restoration approach at Dr Alluris Aesthetics, Londo
  • April 28, 2026

You have probably been watching it happen for a while. A wider parting. More hair on the pillow. The gradual kind of change that you hope will stop on its own until one day you realise it has not.

For most people dealing with androgenetic alopecia — the most common pattern hair loss that affects both men (AGA) and women (FPHL) — the conclusion is eventually the same: that a hair transplant is probably where they are heading. And realistically, this is not an option for most women.

In most cases, that conclusion is wrong. Not because transplants are bad; they have a place for the right candidate, but because most people reaching that point have never had their hair loss properly assessed or treated at the level it actually needs.

What I offer is a different approach entirely. No need for surgery. No need for a haircut. Little to no complications from oral medication. A structured, three-layer programme that addresses the biology of hair loss in a way that most clinics simply do not.

Let me explain why that distinction matters.

Why Your Previous Treatment May Have Plateaued

Hair thinning is not caused by one problem. It is driven by three separate biological mechanisms that work independently of each other, each reinforcing the others over time.

DHT

The Hormonal Driver

The first is DHT — dihydrotestosterone — a hormone derived from testosterone that binds to receptors in susceptible follicles and progressively shortens the growth phase.[1] Over time, it causes the follicle to miniaturise, producing finer and shorter hairs until growth stops altogether.[2]

Vascular Insufficiency

The Supply Problem

The second is vascular insufficiency. The dermal papilla, the cluster of cells at the base of each follicle responsible for signalling new hair growth, depends entirely on blood supply for oxygen and nutrients. As that supply deteriorates, the papilla cells become depleted and the message to grow is no longer sent with sufficient strength.[3]

Inflammation and Oxidative Stress

The Silent Accelerator

The third is chronic scalp inflammation and oxidative stress. Low-grade inflammation and cellular damage accumulate silently over time, degrading the support structures the follicle depends on and accelerating the miniaturisation process.[3][4]

Here is the important part: a treatment that addresses only one of these mechanisms will always plateau. The other two continue unopposed. That is why a course of scalp injections at a standard clinic can show early promise and then stall. The biology was never fully addressed.

A Different Approach

The Dr Alluris Hair Restoration Programme is built around three simultaneous treatment layers, each targeting a different part of the biology. All three run from the first month. None is optional.

Layer One: Cellular Environment

The first layer works at the level of the cellular environment — repairing tissue, supporting follicular cell survival, stimulating growth factor release, and encouraging the formation of new blood vessels around the follicle.[5][6]

Layer Two: Regenerative Signalling

The second layer delivers a concentrated regenerative signal directly to the follicular stem cells, directing the repair process at a deeper biological level. This is not the same mechanism as the first, but it complements it.[7][8]

Layer Three: DHT Management

The third layer is the one most aesthetic clinics do not integrate. DHT management, delivered via microneedling directly at the follicular level, without the systemic side effects of oral medication. Studies on microneedled DHT-blocking agents show that this route achieves higher local concentrations at the follicular target, sustained for longer, than either topical application alone or oral routes, which distribute systemically rather than focally.[9] The suppression happens precisely where the damage is occurring. No drug complications. No systemic hormonal disruption. Nowhere else.

In short:

No surgery. No recovery period. No haircut required. No systemic medication side effects.

What Happens Before Treatment Begins

Before any treatment starts, I carry out a full clinical scalp assessment.

This includes trichoscopy — a detailed examination of the scalp at follicular level — to map the distribution and degree of miniaturisation, and identify which follicles are still viable. It also includes a baseline blood panel, because ferritin deficiency, thyroid dysfunction, and hormonal imbalances are among the most commonly missed drivers of hair thinning. They are frequently the reason previous treatments have underperformed.

The pattern of your hair loss and your individual biology shape every clinical decision that follows. This is not a standard protocol applied identically to every person who walks in. It is a programme built around your specific picture.

What to Honestly Expect

The Shedding Phase

The single most important thing I can tell you about timeline is this: in the first two to four weeks, some people experience a temporary increase in shedding. This is expected, it is a sign the scalp is beginning to respond, and it is not a reason to stop.

The most common reason hair restoration programmes fail is that people stop before month four. Hair biology cannot move faster than the cycle allows, and one full cycle takes three to six months. Results that were weeks away have been abandoned because of early shedding that was misread as failure.

The Timeline

Reduced daily shedding typically becomes noticeable from weeks four to six onwards. Visible improvement in density and hair calibre generally begins to emerge between months three and six, as the three treatment layers compound.[5] A formal review at month six — with repeat trichoscopy and photography — gives us objective data on progress and informs any adjustments to the programme.

 

Important Note on Results

Results are not guaranteed. They depend on the degree of follicular miniaturisation at baseline, how long the loss has been progressing, and consistency with the home treatment component. The programme works best where miniaturised but viable follicles are still present.

Is This Right for You?

The programme suits men and women experiencing hair thinning, diffuse loss, or early to moderate pattern hair loss where follicles are still present. It is also relevant for those who want to arrest progression before it advances further, and for those who have tried single-modality treatments and found the results incomplete.

If you have been watching your hair change and have started thinking that your options are limited, it is worth having a proper assessment before that conclusion becomes a decision.

I see clients at SkinTouch in Crystal Palace (SE19) and at 58 South Molton Street in Mayfair (W1K). You can book a consultation via WhatsApp on 07721 390017, by email at info@drallurisaesthetics.co.uk, or through the link below.

References

  1. Brzezinska-Wcislo L, et al. Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia. Postepy Dermatol Alergol. 2014;31(4):242–9. PMC4171668
  2. Kim JH, et al. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL/6 mice. PubMed. 2021. PMID: 33517191
  3. Trüeb RM, et al. Oxidative stress in androgenetic alopecia. J Investig Dermatol Symp Proc. 2005. PMC5152608
  4. Melo DF, et al. Androgenic alopecia is associated with higher dietary inflammatory index and lower antioxidant index scores. Frontiers in Nutrition. 2024. doi:10.3389/fnut.2024.1433962
  5. Lee SH, et al. Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss. Wound Repair Regen. 2015. PMID: 25524027.
  6. Polynucleotides as a novel therapeutic approach in androgenetic alopecia. PubMed. 2025. PMID: 39951159
  7. Exosomes in trichology: A literature review. PMC. 2025. PMC12814429
  8. Randomised controlled trial: exosome treatment in 58 patients with androgenetic alopecia. International Journal of Trichology. 2020. (78% improvement in hair density vs 27% in control group.)
  9. Topical and microneedled dutasteride vs oral dutasteride: comparative local concentration and systemic exposure. Perfect Hair Health. 2025. perfecthairhealth.com

Related Articles

Browse more articles and find what’s relevant to you.

PRP for Skin and Hair

June 24, 2025
What It Is and Why I Chose a Different Approach Article 7 of 12

Are you ready to start your Journey with Dr Adam

Tap below to book a consultation to discuss your goals, suitability, and a tailored treatment plan with Dr Adam